These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31308636)

  • 1. Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study.
    Dhanda R; Varghese D; Nadipelli VR; Fava M; Joshi N; Solem CT; Graham JA; Learned SM; Heidbreder C
    Patient Prefer Adherence; 2019; 13():1037-1050. PubMed ID: 31308636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study.
    Isitt JJ; Nadipelli VR; Kouassi A; Fava M; Heidbreder C
    Schizophr Res; 2016 Jul; 174(1-3):126-131. PubMed ID: 27066860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6).
    Boye KS; Poon JL; Landó LF; Sapin H; Huh R; Wang M; Williamson S; Patel H
    Diabetes Ther; 2024 Jul; ():. PubMed ID: 39008236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study.
    Ling W; Nadipelli VR; Solem CT; Ronquest NA; Yeh YC; Learned SM; Mehra V; Heidbreder C
    J Subst Abuse Treat; 2020 Mar; 110():1-8. PubMed ID: 31952623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study.
    Ling W; Nadipelli VR; Solem CT; Ronquest NA; Yeh YC; Learned SM; Mehra V; Heidbreder C
    J Addict Med; 2019; 13(6):442-449. PubMed ID: 30844878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia.
    McEvoy JP; Weiden PJ; Lysaker PH; Sun X; O'Sullivan AK
    BMC Psychiatry; 2021 Mar; 21(1):164. PubMed ID: 33761928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 Program.
    Andorn A; Graham J; Csernansky J; Newcomer JW; Shinde S; Muma G; Heidbreder C; Fava M
    J Clin Psychopharmacol; 2019; 39(5):428-433. PubMed ID: 31343440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
    Batt K; Recht M; Cooper DL; Iyer NN; Kempton CL
    Patient Prefer Adherence; 2017; 11():1369-1380. PubMed ID: 28860720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.
    Awad G; Ng-Mak D; Rajagopalan K; Hsu J; Pikalov A; Loebel A
    BMC Psychiatry; 2016 Jun; 16():176. PubMed ID: 27245981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
    Saad F; Thiery-Vuillemin A; Wiechno P; Alekseev B; Sala N; Jones R; Kocak I; Chiuri VE; Jassem J; Fléchon A; Redfern C; Kang J; Burgents J; Gresty C; Degboe A; Clarke NW
    Lancet Oncol; 2022 Oct; 23(10):1297-1307. PubMed ID: 36063830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the correlation and responsiveness of patient-reported pain with function and quality-of-life outcomes after spine surgery.
    DeVine J; Norvell DC; Ecker E; Fourney DR; Vaccaro A; Wang J; Andersson G
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S69-74. PubMed ID: 21897347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EQ-5D-5L and SF-6Dv2 utility scores in people living with chronic low back pain: a survey from Quebec.
    Poder TG; Wang L; Carrier N
    BMJ Open; 2020 Sep; 10(9):e035722. PubMed ID: 32933957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies.
    Kita M; Fox RJ; Gold R; Giovannoni G; Phillips JT; Sarda SP; Kong J; Viglietta V; Sheikh SI; Okwuokenye M; Kappos L
    Clin Ther; 2014 Dec; 36(12):1958-1971. PubMed ID: 25315404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
    Younossi Z; Aggarwal P; Shrestha I; Fernandes J; Johansen P; Augusto M; Nair S
    JHEP Rep; 2022 Sep; 4(9):100525. PubMed ID: 36039144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study.
    Nasser AF; Henderson DC; Fava M; Fudala PJ; Twumasi-Ankrah P; Kouassi A; Heidbreder C
    J Clin Psychopharmacol; 2016 Apr; 36(2):130-40. PubMed ID: 26862829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
    Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
    Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.